Anticholinergic Drugs in Peptic Ulcer: Their Current Status
- 1 March 1957
- journal article
- Published by Elsevier in Medical Clinics of North America
- Vol. 41 (2) , 495-520
- https://doi.org/10.1016/s0025-7125(16)34451-0
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- PRO-BANTHINE IN THE TREATMENT OF PEPTIC ULCERThe Lancet Healthy Longevity, 1956
- STUDIES ON ELORINE SULFATE, AN ANTICHOLINERGIC DRUG*The Lancet Healthy Longevity, 1956
- Clinical evaluation of a sustained release belladonna preparationDigestive Diseases and Sciences, 1955
- The Pharmacology of 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol Methsulfate, Compound 14045, a New Parasympathetic Depressant*Journal of the American Pharmaceutical Association (Scientific ed.), 1954
- The Newer Anticholinergic Agents *Journal of the American Pharmaceutical Association (Scientific ed.), 1954
- The Effect of a New Parasympathetic Blocking Agent on Gastric Secretion and Gastrointestinal Motility in ManDigestion, 1954
- Preliminary evaluation of a new drug, antrenyl. Effect on gastric secretion, motility and results in the symptomatic care of peptic ulcerDigestive Diseases and Sciences, 1953
- EFFECTS OF A NEW CHOLINERGIC BLOCKING AGENT (SKF-1637) ON GASTRIC MOTOR AND SECRETORY ACTIVITYThe Lancet Healthy Longevity, 1952
- PEPTIC ULCERThe Lancet Healthy Longevity, 1952
- Some Clinical Problems in Small Intestinal Physiology Mackenzie Davidson Memorial Lecture, 1950The British Journal of Radiology, 1950